PAR-18-437 - Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 3

Active NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Leveraging transformative connectome resources in model organisms to elucidate the neurobiology of substance use disorders	NOT-DA-21-006	NIDA	Apr 30, 2021	Sep 8, 2024	R01, R03, R21, 333
Notice of Special Interest (NOSI): Exploring the Roles of Biomolecular Condensates (BMCs) in Substance Use Disorder and/or HIV-related processes	NOT-DA-20-018	NIDA	Mar 25, 2020	Sep 8, 2023	R01, R03, R21, 333
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders	NOT-DA-20-021	NIDA	Mar 25, 2020	Sep 8, 2023	R01, R03, R21, K99/R00, R61/R33

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)